Is Atara Biotherapeutics, Inc. (ATRA) a Buy, Sell, or Hold?
NASDAQ : ATRA
Atara Biotherapeutics, Inc. — Competitors
$8.94 USD
$0.33 (3.83%)
- Volume
- 29.23K
- Average Volume
- 1.43M
- Market Capitalization
- $80.55M
- P/E Ratio
- -13.55
- Dividend Yield
- 0.00%
- Price Target
- $13.00
- Year High
- $19.15
- Year Low
- $3.92
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.16
ATRA vs. The Competition
| Properties | ATRA | CLNN | CNTX | COYA |
|---|---|---|---|---|
| Market Cap | $80.55M | $55.84M | $42.8M | $112.59M |
| Shares Outstanding | $9.01M | $12.78M | $91.88M | $23.46M |
| P/E Ratio | -13.55 | -1.34 | -0.97 | -4.49 |
| EPS | -0.67 | -2.88 | -0.48 | -283.64 |
| Day Low | 8.359 | 4.35 | 0.4529 | 4.52 |
| Day High | 9.04 | 5.11 | 0.474 | 4.84 |
| Year Low | 3.92 | 3.5 | 0.432 | 3.71 |
| Year High | 19.145 | 13.5 | 3.62 | 7.75 |
| Average Price 50 | 9.4468 | 5.6952 | 0.85364 | 4.8398 |
| Average Price 200 | 9.19338 | 6.2674 | 1.70176 | 4.98283 |
| Volume | 29234 | 265.06K | 1.21M | 130.17K |
| Average Volume | - | - | - | - |